Literature DB >> 4580829

Acquired toxoplasmosis--selected aspects of diagnosis.

T J Abernethy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4580829      PMCID: PMC2441294     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  9 in total

1.  Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma).

Authors:  A B Sabin; H A Feldman
Journal:  Science       Date:  1948-12-10       Impact factor: 47.728

2.  Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii.

Authors:  B C Walton; B M Benchoff; W H Brooks
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

3.  Non-neoplastic lesions of lymph nodes of man to be differentiated from lymphomas.

Authors:  J J Butler
Journal:  Natl Cancer Inst Monogr       Date:  1969-08

4.  The transmission of toxoplasmosis.

Authors:  L Jacobs
Journal:  Isr J Med Sci       Date:  1968 Sep-Oct

5.  An epidemic of acute toxoplasmosis.

Authors:  B H Kean; A C Kimball; W N Christenson
Journal:  JAMA       Date:  1969-05-12       Impact factor: 56.272

6.  Micro-agglutination test for toxoplasma antibodies.

Authors:  J D Fulton
Journal:  Immunology       Date:  1965-11       Impact factor: 7.397

7.  [Epidemiological study on toxoplasmosis: the influence of cooking slaughter-animal meat on the incidence of human infection].

Authors:  G Desmonts; J Couvreur; F Alison; J Baudelot; J Gerbeaux; M Lelong
Journal:  Rev Fr Etud Clin Biol       Date:  1965-11

8.  Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts.

Authors:  J K Frenkel; J P Dubey; N L Miller
Journal:  Science       Date:  1970-02-06       Impact factor: 47.728

9.  HUMAN TOXOPLASMOSIS: OCCURRENCE IN INFANTS AS AN ENCEPHALOMYELITIS VERIFICATION BY TRANSMISSION TO ANIMALS.

Authors:  A Wolf; D Cowen; B Paige
Journal:  Science       Date:  1939-03-10       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.